Akebia Therapeutics is a biopharmaceutical company specializing in innovative therapies for kidney disease, with two FDA-approved products. The Akebia Therapeutics digital transformation strategy focuses on advancing new product commercialization and expanding its robust drug development pipeline. This approach involves leveraging advanced cloud technologies and its Oracle ERP Cloud system to support critical internal operations and external collaborations.
This transformation creates significant dependencies on accurate data, integrated systems, and streamlined workflows across its entire lifecycle from research to commercialization. Critical systems like Oracle ERP and Google Cloud become central to managing complex processes in clinical trials, supply chain, and regulatory affairs. This page analyzes Akebia Therapeutics' key initiatives, the operational challenges they introduce, and where these breakdowns create opportunities for specialized solutions.
Akebia Therapeutics Snapshot
Headquarters: Cambridge, USA
Number of employees: 194
Public or private: Public
Business model: B2B
Website: http://www.akebia.com
Akebia Therapeutics ICP and Buying Roles
Akebia Therapeutics sells to large and complex healthcare organizations, including dialysis providers and hospital systems.
-
Who drives buying decisions
-
Chief Medical Officer → Clinical trial design and execution oversight, patient safety.
-
Chief Financial Officer → Financial planning, budget allocation for technology investments.
-
Chief Commercial Officer → Product launch strategy, market access, sales force effectiveness.
-
Senior Vice President, Chief Research & Development Officer → Pipeline progression, clinical development strategies.
-
Senior Vice President, Chief Technology Officer → Technology infrastructure, system integrations, data security.
Key Digital Transformation Initiatives at Akebia Therapeutics (At a Glance)
- Centralizing clinical trial data management.
- Automating commercial product market access.
- Orchestrating R&D pipeline development workflows.
- Standardizing global supply chain data in Oracle ERP.
- Streamlining regulatory submission data preparation.
Where Akebia Therapeutics’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Trial Management Platforms | Centralizing clinical trial data management: disparate data sources create inconsistencies in patient records. | Chief Medical Officer, Head of Clinical Operations | Consolidate data from multiple clinical sites into a single platform. |
| Centralizing clinical trial data management: monitoring patient safety events requires manual cross-referencing across systems. | Chief Medical Officer, Head of Clinical Operations | Detect adverse event patterns automatically across trial data. | |
| Centralizing clinical trial data management: remote monitoring workflows lack real-time data synchronization. | Head of Clinical Operations, Senior Manager, Clinical Supply Chain | Standardize data flow from remote devices to central repositories. | |
| Market Access & Commercial Platforms | Automating commercial product market access: disparate regional data prevents unified patient access reporting. | Chief Commercial Officer, Head of Market Access | Consolidate patient access data from all geographic regions. |
| Automating commercial product market access: processing new prescriber enrollments includes manual data entry across systems. | Chief Commercial Officer, Head of Market Access | Route prescriber information automatically into commercial CRM systems. | |
| Automating commercial product market access: managing varied dosing protocols requires manual updates across dialysis centers. | Chief Commercial Officer, Head of Sales | Enforce consistent protocol configuration across all affiliated treatment centers. | |
| R&D Workflow Orchestration Tools | Orchestrating R&D pipeline development workflows: data handoffs between preclinical and clinical teams fail to integrate. | Senior Vice President, Chief Research & Development Officer, Head of R&D Operations | Validate data integrity at each stage of the drug development lifecycle. |
| Orchestrating R&D pipeline development workflows: managing numerous investigational products lacks a centralized tracking system. | Senior Vice President, Chief Research & Development Officer, Head of R&D Operations | Route new drug candidates through defined development gates. | |
| Supply Chain Data Management Platforms | Standardizing global supply chain data in Oracle ERP: inventory reconciliation requires manual data validation. | Chief Financial Officer, Senior Manager, Supply Chain | Standardize inventory data across global manufacturing sites within the ERP system. |
| Standardizing global supply chain data in Oracle ERP: master data inconsistencies block automated reordering processes. | Chief Financial Officer, Senior Manager, Supply Chain | Detect master data discrepancies before production planning cycles. | |
| Regulatory Compliance & Submission Tools | Streamlining regulatory submission data preparation: compiling post-marketing safety data involves manual aggregation from multiple sources. | Chief Legal Officer, Head of Regulatory Affairs | Consolidate global post-marketing safety data into a centralized repository. |
| Streamlining regulatory submission data preparation: ensuring 21 CFR Part 11 compliance for electronic records lacks automated audit trails. | Chief Legal Officer, Head of Regulatory Affairs | Enforce electronic record-keeping standards with automated audit trails. |
Identify when companies like Akebia Therapeutics are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Akebia Therapeutics’s digital transformation unique
Akebia Therapeutics’s digital transformation uniquely prioritizes integrating complex clinical and commercial data to accelerate drug development and market penetration for kidney disease therapies. They heavily depend on their Oracle ERP Cloud and Google Cloud infrastructure to manage vast amounts of R&D data, ensuring compliance and supporting global supply chains. This dual focus on rigorous clinical trial execution and rapid commercialization, especially for products like Vafseo, creates distinct data integrity and workflow orchestration challenges not typically seen in other industries.
Akebia Therapeutics’s Digital Transformation: Operational Breakdown
DT Initiative 1: Centralizing Clinical Trial Data Management
What the company is doing
Akebia Therapeutics manages global Phase 3 clinical trial programs for investigational therapies, such as Vafseo, and also for new pipeline candidates. This involves collecting vast amounts of data from numerous sites and managing a complex array of patient information and safety events. They implement remote monitoring capabilities to oversee ongoing studies efficiently.
Who owns this
- Chief Medical Officer
- Head of Clinical Operations
- Senior Vice President, Chief Research & Development Officer
Where It Fails
- Clinical data acquisition from diverse global sites does not standardize before ingestion into central databases.
- Patient safety reporting requires manual cross-referencing of data across multiple clinical systems.
- Remote monitoring systems fail to synchronize real-time patient data into the primary clinical database.
- Trial data integrity breaks when manual data transfers introduce transcription errors.
Talk track
Noticed Akebia Therapeutics is centralizing clinical trial data management for new drug candidates. Been looking at how some biopharma teams are standardizing data schemas upfront instead of reconciling discrepancies later, happy to share what we’re seeing.
DT Initiative 2: Automating Commercial Product Market Access
What the company is doing
Akebia Therapeutics expands market access for commercial products like Vafseo by increasing prescriber adoption and implementing dosing protocols across dialysis organizations. This effort involves broad engagement with key dialysis providers to broaden patient access and establish Vafseo as a standard of care.
Who owns this
- Chief Commercial Officer
- Head of Market Access
- Head of Sales
Where It Fails
- Prescriber enrollment forms require manual data entry across multiple commercial systems.
- Geographic patient access data fails to consolidate for a unified market overview.
- Dialysis center protocol updates do not propagate automatically across the entire network.
- Reimbursement tracking requires manual reconciliation against varying payer guidelines.
Talk track
Saw Akebia Therapeutics is automating commercial product market access for Vafseo. Been looking at how some pharma teams are routing prescriber data directly into CRM without manual entry, can share what’s working if useful.
DT Initiative 3: Orchestrating R&D Pipeline Development Workflows
What the company is doing
Akebia Therapeutics aggressively progresses a mid-stage pipeline of rare kidney disease therapies, including praliciguat, AKB-097, and AKB-9090. This involves moving drug candidates through preclinical, Phase 1, and Phase 2 trials, requiring seamless data and workflow orchestration between research teams.
Who owns this
- Senior Vice President, Chief Research & Development Officer
- Head of R&D Operations
- Head of Program Management
Where It Fails
- Data handoffs between preclinical research and clinical development teams create integration gaps.
- Investigational product tracking lacks a unified system across all pipeline stages.
- Research data does not propagate automatically into downstream trial management systems.
- Go/no-go decisions require manual aggregation of data from multiple research streams.
Talk track
Looks like Akebia Therapeutics is orchestrating R&D pipeline development workflows for new therapies. Been seeing some biopharma companies standardize data handoffs between research phases to prevent information loss, happy to share what we’re seeing.
DT Initiative 4: Standardizing Global Supply Chain Data in Oracle ERP
What the company is doing
Akebia Therapeutics optimizes its global supply chain operations, focusing on inventory management, forecasting, and master data control within its Oracle Cloud ERP system. This ensures the continuous supply of raw materials, APIs, and finished products for both commercial and clinical needs.
Who owns this
- Chief Financial Officer
- Senior Manager, Supply Chain
- Head of CMC Operations
Where It Fails
- Inventory master data in Oracle ERP shows inconsistencies across different product SKUs.
- Supply planning forecasts do not integrate real-time demand signals from commercial teams.
- Raw material traceability breaks when batch information is manually entered into the ERP.
- Warehouse storage reconciliation requires manual audits due to system discrepancies.
Talk track
Seems like Akebia Therapeutics is standardizing global supply chain data in Oracle ERP. Been seeing some biopharma teams detect master data discrepancies automatically to prevent production delays, can share what’s working if useful.
DT Initiative 5: Streamlining Regulatory Submission Data Preparation
What the company is doing
Akebia Therapeutics prepares comprehensive New Drug Applications (NDAs) and other regulatory filings, including post-marketing safety data from tens of thousands of patients. This process demands adherence to strict compliance standards, such as 21 CFR Part 11 for electronic records and batch traceability requirements.
Who owns this
- Chief Legal Officer
- Head of Regulatory Affairs
- Head of Quality Assurance
Where It Fails
- Post-marketing safety data aggregation involves manual extraction from disparate international databases.
- Electronic record submissions lack automated audit trails for 21 CFR Part 11 compliance.
- Regulatory document version control fails to synchronize across global review teams.
- Batch traceability information requires manual validation before inclusion in submission packages.
Talk track
Noticed Akebia Therapeutics is streamlining regulatory submission data preparation for new approvals. Been looking at how some biopharma companies enforce electronic record standards with automated audit trails, happy to share what we’re seeing.
Who Should Target Akebia Therapeutics Right Now
This account is relevant for:
- Clinical trial management system providers
- Life sciences commercial operations platforms
- R&D workflow automation and orchestration tools
- ERP extensions for pharmaceutical supply chain management
- Regulatory information management (RIM) solutions
- Data quality and governance platforms for GxP environments
Not a fit for:
- Generic marketing automation tools
- Basic IT help desk solutions
- Consumer-facing wellness applications
- Broad HR management systems
- Infrastructure providers without compliance expertise
When Akebia Therapeutics Is Worth Prioritizing
Prioritize if:
- You sell solutions for centralizing fragmented clinical trial data for faster analysis.
- You sell platforms that automate the routing of prescriber information into commercial CRM systems.
- You sell tools that standardize data handoffs between R&D phases to prevent information loss.
- You sell ERP extensions that detect master data discrepancies before production planning cycles in Oracle.
- You sell systems that enforce electronic record-keeping standards with automated audit trails for regulatory compliance.
Deprioritize if:
- Your solution does not address any of the breakdowns above.
- Your product is limited to basic functionality without advanced data integration capabilities.
- Your offering is not built for complex regulatory environments like biopharmaceuticals.
Who Can Sell to Akebia Therapeutics Right Now
Clinical Trial Data Management Platforms
Veeva Systems - This company provides cloud-based software for the life sciences industry, including clinical operations and data management.
Why they are relevant: Clinical trial data acquisition from diverse global sites does not standardize before ingestion into central databases. Veeva can provide a unified platform to standardize and manage clinical data across all phases and locations, reducing inconsistencies and manual data processing.
Medidata Solutions - This company offers a unified platform for clinical research, including data capture, management, and analytics.
Why they are relevant: Patient safety reporting requires manual cross-referencing of data across multiple clinical systems. Medidata's platform can automate the collection and analysis of safety data, enabling faster detection of adverse events and improving reporting accuracy.
Parexel Biotech - This company offers clinical research services and technology solutions, including trial master file (TMF) systems and data management.
Why they are relevant: Remote monitoring systems fail to synchronize real-time patient data into the primary clinical database. Parexel's solutions can integrate remote monitoring data feeds, ensuring consistent and real-time synchronization with central trial records.
Commercial Operations & Market Access Platforms
IQVIA - This company provides advanced analytics, technology solutions, and contract research services for the life sciences industry, focusing on commercial effectiveness.
Why they are relevant: Prescriber enrollment forms require manual data entry across multiple commercial systems. IQVIA can offer integrated platforms to automate the intake and routing of prescriber data directly into commercial CRMs, eliminating manual effort and reducing errors.
Model N - This company provides cloud-based revenue management solutions for the life sciences sector, including gross-to-net and market access.
Why they are relevant: Geographic patient access data fails to consolidate for a unified market overview. Model N can help integrate and analyze patient access data from various regions, providing a comprehensive and real-time view of market penetration for commercial products.
Accenture Life Sciences - This company offers consulting and technology services, including commercial strategy and digital transformation for pharma.
Why they are relevant: Dialysis center protocol updates do not propagate automatically across the entire network. Accenture can implement solutions that standardize and automate the distribution of new dosing protocols, ensuring consistent application across all affiliated treatment centers.
R&D Workflow Orchestration Tools
Dotmatics - This company provides R&D scientific software solutions, including data management, electronic lab notebooks (ELN), and laboratory information management systems (LIMS).
Why they are relevant: Data handoffs between preclinical research and clinical development teams create integration gaps. Dotmatics can provide a unified R&D platform that ensures seamless data flow and integrity at each stage of the drug development lifecycle.
ArisGlobal - This company offers life sciences software solutions for drug development, including clinical, regulatory, safety, and medical affairs.
Why they are relevant: Investigational product tracking lacks a unified system across all pipeline stages. ArisGlobal's platform can offer a centralized system to track and manage all drug candidates through their various preclinical and clinical development phases.
Supply Chain & Manufacturing ERP Extensions
Blue Yonder - This company provides AI-driven supply chain planning and execution solutions.
Why they are relevant: Inventory master data in Oracle ERP shows inconsistencies across different product SKUs. Blue Yonder can integrate with Oracle ERP to standardize and validate master data, preventing discrepancies that impact production planning.
Kinaxis - This company offers cloud-based software for supply chain planning and concurrent planning.
Why they are relevant: Supply planning forecasts do not integrate real-time demand signals from commercial teams. Kinaxis can enable concurrent planning by integrating real-time commercial demand with supply chain planning, ensuring more accurate forecasts and reducing stockouts.
Regulatory Information Management (RIM) Solutions
Extedo - This company provides regulatory information management (RIM) and pharmacovigilance solutions for life sciences.
Why they are relevant: Post-marketing safety data aggregation involves manual extraction from disparate international databases. Extedo can provide a centralized platform to consolidate global safety data, streamlining the aggregation process for regulatory submissions.
Envision Pharma Group - This company offers scientific communication, medical affairs, and technology solutions, including regulatory affairs platforms.
Why they are relevant: Electronic record submissions lack automated audit trails for 21 CFR Part 11 compliance. Envision Pharma Group can implement solutions that ensure automated audit trails for all electronic records, meeting strict regulatory requirements.
Final Take
Akebia Therapeutics is scaling its Vafseo commercialization and aggressively advancing its drug development pipeline, leading to visible breakdowns in clinical data management, market access automation, R&D workflow orchestration, Oracle ERP supply chain data, and regulatory submission preparation. This account is a strong fit for vendors whose solutions prevent these specific operational failures, especially those that standardize data, automate compliance checks, and integrate complex workflows across the biopharmaceutical ecosystem.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.